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Background: Gamma-aminobutylate (GABA) is an important chemical in pharmacetucal field and chemical
industry. GABA has mostly been produced in lactic acid bacteria by adding L-glutamate to the culture medium
since L-glutamate can be converted into GABA by inherent L-glutamate decarboxylase. Recently, GABA has gained
much attention for the application as a major building block for the synthesis of 2-pyrrolidone and biodegradable
polyamide nylon 4, which opens its application area in the industrial biotechnology. Therefore, Corynebacterium
glutamicum, the major L-glutamate producing microorganism, has been engineered to achieve direct fermentative
production of GABA from glucose, but their productivity was rather low.
Results: Recombinant C. glutamicum strains were developed for enhanced production of GABA from glucose by
expressing Escherichia coli glutamate decarboxylase (GAD) mutant, which is active in expanded pH range. Synthetic
PH36, PI16, and PL26 promoters, which have different promoter strengths in C. glutamicum, were examined for the
expression of E. coli GAD mutant. C. glutamicum expressing E. coli GAD mutant under the strong PH36 promoter could
produce GABA to the concentration of 5.89 ± 0.35 g/L in GP1 medium at pH 7.0, which is 17-fold higher than that
obtained by C. glutamicum expressing wild-type E. coli GAD in the same condition (0.34 ± 0.26 g/L). Fed-bath
culture of C. glutamicum expressing E. coli GAD mutant in GP1 medium containing 50 μg/L of biotin at pH 6,
culture condition of which was optimized in flask cultures, resulted in the highest GABA concentration of 38.6 ± 0.85 g/L
with the productivity of 0.536 g/L/h.
Conclusion: Recombinant C. glutamicum strains developed in this study should be useful for the direct fermentative
production of GABA from glucose, which allows us to achieve enhanced production of GABA suitable for its application
area in the industrial biotechnology.
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Gamma-aminobutyrate (GABA), is a non-protein amino
acid, which is synthesized in many microorganisms,
plants and animals [1]. GABA has been used as a bio-
active component in various foods and pharmaceutical
products due to its potential in controlling neurotrans-
mitter signal and lowering blood pressure in human
[2-4]. In addition, GABA has been used as a major
building block for the synthesis of 2-pyrrolidone and
biodegradable polyamide nylon 4, which opens its appli-
cation area in the industrial biotechnology [5,6]. Thus,
the development of strategy for economical production
of GABA become an important issue to meet its expand-
ing demand in the various areas from a high value added
business such as pharmaceuticals to biomass-based indus-
try such as bioplastics and biochemicals.
Since GABA can be produced by decarboxylation of glu-
tamate, the strategy of biological production of GABA has
been based on the efficient conversion of glutamate into
GABA by glutamate decarboxylase (GAD; EC 4.1.1.15).
Purified GAD and natural and recombinant microorgan-
isms expressing GAD have been employed for the conver-
sion of glutamate monosodium salt (MSG) or glutamic
acid to GABA. Recent studies have suggested that GABA
can be efficiently produced from L-glutamate by some
lactic acid bacteria (LAB) [7,8] and recombinant Escherichia
coli [5,9,10]. Basically, it is needed to develop additional en-
zymatic and whole cell mediated conversion of MSG into
GABA when fermentation-derived MSG is used for the pro-
duction of GABA. Even though GABA can be efficiently
produced from MSG by enzymatic and whole cell biocata-
lytic processes, these processes might be complex to design
for industrial-scale production of GABA compared with dir-
ect fermentative production of GABA from glucose due to
the need for additional processes to link MSG and GABA
production process. Recently, C. glutamicum has drawn
much attention as an alternative host for direct fermentative
production of GABA from renewable carbon sources since
it has already been used as an industrial host strain for the
production of amino acids such as MSG and Lysine by
fermentation with an annual production of more than
1.5 million tons [11-14]. C. glutamicum is a Gram (+),
non-pathogenic and non-spore forming bacterium that
has been traditionally used for the production of various
amino acids [15-18] and is generally regarded as safe
(GRAS) which is suitable for the production of foods and
pharmaceutical products [19]. Recently, fermentative pro-
duction of GABA from renewable carbon sources has
been reported by recombinant C. glutamicum strains.
Recombinant C. glutamicum expressing Lactobacillus
brevis glutamate decarboxylase successfully produced
GABA up to 26 g/L in 120 h fermentation [12]. Also,
C. glutamicum expressing E. coli glutamate decarb-
oxylase, which was further engineered by the deletionof the pknG gene encoding serine/threonine protein
kinase G, resulted in the production of 31 g/L of
GABA in 120 h fermentation [11]. In these studies,
wild-type glutamate decarboxylases that have optimal
pH around 4.5 for their decarboxylation of glutamate
were employed for the production of GABA, but the
optimal culture pH of C. glutamicum strain for its
growth was much higher than 4.5. Due to the discrep-
ancy of optimal pH between activity of GAD and cell
growth, GABA could not be produced during the ex-
ponential growth phase in which both the cell growth
and the synthesis of glutamate, the direct substrate for
GABA, were active. The direct conversion for GABA
was initiated in stationary growth phase when the culture
pH was relatively lower than initial pH [14]. GABA was
produced and this was the main reason for relatively long
time cultivation over 120 h, which resulted in low GABA
productivity.
In this study, we have developed recombinant C.
glutamicum strains that efficiently produce GABA in
culture pH around 5 ~ 7 by employing E. coli GAD
mutant active in expanded pH range, which can ultimately
provide balanced condition for cell growth and GABA pro-
duction. Optimal expression conditions of E. coli GAD
mutant (Glu89Gln/Δ452-466), in which C-terminal region
is removed and contains mutation of Glu89Gln [20], were
designed based on synthetic promoters active in recombin-
ant C. glutamicum [21]. Finally, fed-batch cultivation strat-
egies of recombinant C. glutamicum expressing E. coli
GAD mutant were developed for enhanced production of
GABA from glucose.
Results
Comparison of activity of E. coli wild type and mutant
GADs in recombinant C. glutamicum
For biosynthesis of GABA, GAD plays the key role but
its low optimal pH range (~ pH 4) has been critical limi-
tation because its optimal pH for catalytic activity is not
suitable for the growth of most recombinant hosts in-
cluding E. coli and C. glutamicum [22]. Recently, E. coli
GadB mutant (Glu89Gln/Δ452-466) having catalytic ac-
tivity in broadened pH range up to pH 7 was developed
by engineering E. coli GadB [20], which might allow us
to achieve enhanced production of GABA since culture
conditions for cell growth and synthesis of L-glutamate,
the direct precursor of GABA, can be optimized for
GABA production in broadened culture pH conditions.
First, we constructed recombinant C. glutamicum strains
expressing E. coli wild-type GadB and engineered E. coli
GadB under the strong synthetic H36 promoter and
compared these strains in the respective of GABA pro-
duction in GP1 medium containing 500 μg/L biotin at
30°C and initial pH 7. Under the strong and constitutive
PH36 promoter, both the gadB mutant gene and the wild
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could be produced with high solubility (Figure 1A). Re-
combinant C. glutamicum harboring pHGmut success-
fully produced GABA to the concentration of 5.89 ±
0.35 g/L, but recombinant C. glutamicum harboring pHGwt
produced much lower GABA to the concentration of 0.34 ±
0.26 g/L (Figure 1B). It is well-known that C. glutamicum
expressing wild type gadB genes could produce GABA
when they were cultivated at low pH conditions [13,14].
But, in the near-neutral pH condition, the wild type GAD
has much lower activity, and as expected, the small
amount of GABA was produced by the expression of wild
type GAD in C. glutamicum (Figure 1B).Figure 1 Comparison of GABA production in C. glutamicum
producing wild type GAD or mutant GAD in flaks cultivation.
(A) SDS-PAGE analysis of production of wild type GAD and mutant
GAD. Lane M, protein size markers (kDa). Lanes 1 and 2, C. glutamicum
harboring pCES208. Lanes 3 and 4, C. glutamicum harboring pHGwt.
Lanes 5 and 6, C. glutamicum harboring pHGmut. Lanes 1, 3, and 5,
total protein fractions. Lanes 2, 4, and 6, soluble protein fractions. The
open and closed arrowheads indicate the band of wild type GAD and
mutant GAD, respectively. (B) Time profiles of GABA concentration.
Diamond and circle symbols indicate C. glutamicum harboring
pHGwt and pHGmut, respectively.Effect of promoter strength on GABA production in
recombinant C. glutamicum
To achieve the high-level production of biomolecules in
bacterial host, it is one of the important issues to con-
struct the gene expression system which expresses the
enzymes responsible for the production of target prod-
ucts with high solubility and functionality. In general,
the use of strong promoter is preferred for overproduc-
tion of such enzymes, but in some cases, the overpro-
duction of enzymes caused the insoluble aggregates
which do not have any biological functions. Therefore, it
is needed to find the proper promoter which allows the
optimal gene expression and high-level production of
target molecules, and for this purpose, we have exam-
ined promoters which have different promoter strengths.
Previously, we succeeded in the isolation of 20 synthetic
promoters which can mediate the constitutive gene ex-
pression in recombinant C. glutamicum [21]. Among 20
synthetic promoters, two more promoters, PL26 and PI16,
were chosen for further examination since they have dif-
ferent promoter strengths in the order of PL26, PI16, and
PH36 [21]. Each construct (pLGmut, pIGmut, or pHGmut)
was transformed into C. glutamicum and, gene expression
and GABA production were examined in flask cultivation
(30°C and pH 7). E. coli gadB mutant gene was well
expressed under all promoters with high solubility
(Figure 2A). But the expression level under each pro-
moter was very similar and so it was not easy to
choose the promoter for gene expression. For further
evaluation of three synthetic promoters, the culture
supernatants were collected periodically during the
cultivation, and the GABA production yields were ana-
lyzed. During cultivations, the culture supernatants
were collected periodically and the GABA production
yields were analyzed. All the recombinant C. glutamicum
harboring pLGmut, pIGmut, and pHGmut, respectively,
successfully produced GABA and GABA concentration
continued to increase during cultivation. It was also found
that GABA concentrations obtained by each recombinant
C. glutamicum were highly correlated with the strength of
promoters although gene expression levels under three
promoters were similar. Among three promoters, the use
of strong promoter (PH36) resulted in the highest GABA
concentration (5.89 ± 0.35 g/L) than those of other pro-
moters (5.32 ± 0.04 g/L under PI16 and 4.87 ± 0.15 g/L
under PL26) after 96 h (Figure 2B). Therefore, in all follow-
ing works, the strong synthetic promoter (PH36) was used
for the expression of gadB mutant gene in C. glutamicum.
Effect of biotin concentration on GABA production
For the enhanced production of GABA, the pool of its
direct precursor, L-glutamate, should be increased in a
production host [11]. It is well known that overproduc-
tion of L-glutamate is induced in C. glutamicum under
Figure 3 Time profiles of cell density and GABA concentrations
during flask cultivations with different biotin concentrations.
Square, circle, triangle and diamond symbols indicate 1 μg/L, 50 μg/L,
100 μg/L, and 500 μg/L, respectively. (A) Time profiles of cell growth at
four different biotin concentration conditions. (B) Open and
closed symbols indicate the L-glutamate concentrations and
GABA concentrations, respectively. Each point represents the average
of three independent experiments. Each point represents the average
of three independent experiments.
Figure 2 Comparison of three different promoters for gene
expression and GABA production in C. glutamicum. (A) SDS-PAGE
analysis of mutant GAD gene expression under the three synthetic
promoters (PL26, PI16, or PH36). Lane M, protein size markers (kDa).
Lanes 1 and 2, C. glutamicum harboring pCES208.Lanes 3 and 4,
C. glutamicum harboring pLGmut. Lanes 5 and 6, C. glutamicum
harboring pIGmut. Lanes 7 and 8, C. glutamicum harboring pHGmut.
Lanes 1, 3, 5, and 7, total protein fractions. Lanes 2, 4, 6, and 8, soluble
protein fractions. (B) Time course of GABA concentration during flask
cultivation of C. glutamicum. Triangle, square, circle and diamond
symbols indicate C. glutamicum harboring pLGmut, pIGmut,
pHGmut and pHGwt respectively. Each point represents the average
of three independent experiments.
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of biotin in culture medium can give a positive effect on
GABA production [23-26]. However, C. glutamicum is a
biotin auxotrophic bacterium, which requires high-level
concentration of biotin for cell growth, thus, it is neces-
sary to optimize a biotin concentration for the enhanced
production of GABA without cell growth retardation. To
find the optimal concentration of biotin, C. glutamicum
harboring pHGmut was cultivated in the GP1 medium
containing four different biotin concentrations; 1 μg/L,
50 μg/L, 100 μg/L and 500 μg/L. In these experiments, the
initial pH in the medium was adjusted to 7. In all concen-
trations of biotin except for 1 μg/L, cells exhibited similar
growth patterns and could grow up to 20~22 of OD600
(Figure 3). In contrast, supplementation of the 1 μg/L of
biotin resulted in the retardation of cell growth and lower
final cell density (17 of OD600). The highest GABA concen-
tration of 6.32 ± 0.38 g/L was obtained by the cultivationof recombinant C. glutamicum (pHGmut) in GP1 medium
supplemented with 50 μg/L of biotin (Figure 3). In each
cultivation, the level of glutamate was also determined and
we found that the supplementation of 50 μg/L biotin ex-
hibited the highest level of glutamate in the early stage
(24 hr) and most of them was consumed in the period of
GABA production (Figure 3B). This result clearly indicates
that the optimization of biotin concentration can be
one of the critical factors in the production of GABA
by C. glutamicum.
Effect of pH on GABA production
In contrast to wild type GAD having optimal pH around
4 [20], the pH spectrum for catalytic activity of the mu-
tant GAD was expanded to near-neutral pH range,
which is also optimal for cell growth [20]. Even though
mutant GAD has catalytic activity in the range of pH 4
and pH 7, it was reported that specific activity of mutant
GAD was gradually decreased to almost zero as the re-
action pH increased from 4 to 8 [20]. Also, synthesis of
glutamate, the precursor of GABA, might be different
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combinant C. glutamicum. Thus, cultivations of recom-
binant C. glutamicum harboring pHGmut were examined
at three different pH conditions (pH 4, pH 5 and pH 6) to
find the optimal pH for GABA production, and the results
of cell growth and GABA production were compared with
those of cultivation at pH 7. In cultivation at pH 4, cells
did not show any growth (Figure 4A) and GABA concen-
tration was also very low (0.29 ± 0.04 g/L) (Figure 4B). In
contrast, cultivation at higher pH conditions (pH 5 and
pH 6) resulted in much better cell growth than that of cul-
tivation at pH 4 (Figure 4B), but a little slower growth
than that of cultivation at pH 7 (Figure 4A). At both pH
conditions, cells grew well up to 19 and 21 of OD600, re-
spectively. During the cultivation at pH 5, the pH was well
maintained in entire cultivation for 96 h, but, cultivation
at pH 6 showed a little decrease of pH to 5.5 in late stage
of cultivation (Figure 4A). At both pH conditions, the con-
centrations of GABA produced during cultivations grad-
ually increased (Figure 4B). Particularly, cultivation at
pH 5 resulted in higher GABA concentration of 8.34 ±Figure 4 Effect of pH on cell growth and GABA production in
flask cultivation of C. glutamicum. (A) Time profiles of cell growth
and pH change at four different pH conditions. Triangle, circle and
square symbols indicate the pH 4, pH 5 and pH 6, respectively. The
open and closed symbols indicate the cell density and pH change,
respectively. (B) Time profiles of GABA concentrations during
cultivations. Triangle, and circle and square symbols indicate pH 4,
pH 5 and pH 6, respectively. Each point represents the average of
three independent experiments.0.26 g/L than those obtained in the cultivations at higher
pH conditions (pH 6 and pH 7). In cultivation at pH 6, a
little higher GABA concentration of 6.60 ± 0.64 g/L was
obtained than that at pH 7. Also, volumetric productivity
of 0.11 g/L/h obtained in cultivation at pH 5 was higher
than those obtained at pH 6 (0.09 g/L/h) and pH 7
(0.08 g/L/h).
Fed-batch cultivations for GABA production
Fed-batch cultivations of recombinant C. glutamicum
harboring pHGmut were carried out for the high-level
production of GABA from glucose in 5 L lab-scale bio-
reactor containing GP1 medium supplemented with
50 μg/L of biotin. In cultivation at pH 5, cells grew up
to 76.6 of OD600 in 72 h and cell specific growth rate (μ)
was 0.055 h−1 (Figure 5A). The initial glucose (100 g/L)
was gradually consumed during cultivation and glucose
concentration was maintained at 30 g/L by periodically
supplying nutrient feeding solution (Figure 5A). It wasFigure 5 Fed-batch cultivation for GABA production with
different pH conditions. (A) Time profiles of cell growth and
glucose concentration. Circle, triangle, and square symbols indicate
pH 5, pH 6 and pH 7, respectively. Open and closed symbols
indicate the glucose concentration and cell density, respectively.
(B) Time profiles of L-glutamate and GABA concentrations. Circle,
triangle, and square symbols indicate pH 5, pH 6 and pH 7,
respectively. Open and closed symbols indicate the GABA and
glutamate concentrations, respectively. The first time points for
glucose feeding were indicated by gray-solid (pH 5), black-dashed
(pH 6) and black-solid (pH 7) arrows.
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nential cell growth phase. GABA concentration reached
14.0 ± 0.46 g/L in 72 h and the maximum volumetric
productivity was 0.194 g/L/h (Figure 5B). Total amount
of glucose supplied was 372 ± 2.9 g and the molar yield
of GABA from glucose was 0.197 mol/mol glucose. In
the early growth phase, small amount of L-glutamate
was accumulated but after entering to the mid-log
growth phase (36 h), the concentration of L-glutamate
was maintained at almost zero (Figure 5B).
Fed-batch cultivation of C. glutamicum harboring
pHGmut was also performed at pH 6 condition. At
pH 6, cells exhibited much faster cell growth than that
at pH 5. During exponential growth phase, cell specific
growth rate (μ) was 0.11 h−1 which was almost 2-fold
faster than that at pH 5 (Figure 5A). The maximum
cell density of 167 of OD600 was also much higher than
that at pH 5. As cell entered to exponential growth
phase (in 24 h), the glutamate concentration in culture
medium was maintained at almost zero (Figure 5B). As
cell grew exponentially, GABA production also grad-
ually increased. GABA concentration of 38.6 ± 0.85 g/L
was obtained in 72 h culture, which was 2.7-fold higher
than that at pH 5 and the maximum volumetric product-
ivity was 0.536 g/L/h (Figure 5B). Total amount of glucose
supplied was 482 ± 3.4 g and the molar yield from glucose
was 0.560 mol/mol glucose.
Finally, fed-batch cultivation of C. glutamicum for
GABA production was performed in pH 7. At pH 7, a
specific growth rate (μ = 0.10 h−1) similar to that at
pH 6 was obtained the maximum cell density reached to
162 of OD600 in 60 h, which were similar to those at
pH 6 (Figure 5A). While the glutamate concentration
was maintained at almost zero during fed-batch cultiva-
tion at pH 5 and 6, it was found out that significant
amount of L-glutamate was accumulated during fed-
batch culture at pH 7. Accumulation of glutamate was
detected after 36 h cultivation, and its concentration
reached 18.9 ± 0.71 g/L at the end of cu-ltivation (Figure 5B).
According to accumulation of glutamate, relatively low
GABA concentration of 9.86 ± 0.52 g/L was obtained
and maximum volumetric productivity was 0.136 g/L/h
(Figure 5B). Total amount of glucose supplied was
consumed 498 ± 7.4 g and the molar yield from glu-
cose was 0.103 mol/mol glucose.
Discussion
For the enhanced production of target products such as re-
combinant proteins, biochemical and biopolymers, the effi-
cient expression system of inherent and heterologous
genes needs to be constructed. For this purpose, the choice
of proper promoter is an important issue but, unfortu-
nately, only a few promoters are available in C. glutamicum
and it is not easy to find the proper promoter forhigh-level gene expression in C. glutamicum [27,28].
Previously, we succeeded in the isolation of fully synthetic
promoters which made constitutive gene expression with
different strengths in C. glutamicum [21,29]. By examining
different promoters, the best system for the high-level ex-
pression of target gene in C. glutamicum could be con-
structed [21]. In this work, we examined three synthetic
promoters having different promoter strength, which have
been screened in previous study [21] for the construction
of recombinant C. glutamicum to achieve enhanced pro-
duction of GABA from glucose. Among three synthetic
promoters, PL26, PI16, and PH36, which have different pro-
moter strengths in the order of PL26, PI16, and PH36, the
use of PH36 promoter allowed the high-level expression of
GAD along with much enhanced production of GABA.
This can be another example to prove the usefulness of
the synthetic promoters for high-level gene expression in
C. glutamicum.
For the higher production of target products including
recombinant proteins and metabolites, cells need to be
cultivated to high cell density (generally higher than OD =
100), and for this purpose, fed-batch cultivations have
widely been used in which pH was set at optimal pH for
cell growth. However, instead of fed-batch cultivations,
batch cultivations have been used for GABA production,
in which pH was not adjusted during the cultivation for
the production of GABA due to the characteristics of
wild-type GAD, the main catalyst for the conversion of
glutamate into GABA. Since the wild-type GAD has op-
timal catalytic activity only in low pH range around 4
and it has almost no enzyme activity at pH higher than
4, thus, two stage cultivation strategy has generally been
employed for GABA production to satisfy the condi-
tions for cell growth and GABA production. The batch
cultivations were divided to two stages: i) cell growth
stage and ii) GABA production stage. When the culture
pH was in the range suitable for cell growth, cells grew
well without much GABA production since GAD has
very little catalytic activity. As the cells entered into the
stationary phase, in which pH began to decrease without
further cell growth, GABA production began to increase
since GAD became active in the low pH condition.
However, high-level production of GABA could not be
achieved in such batch type cultivations since high cell
density of cells expressing GAD gene could not be
achieved and GABA was produced only in stationary
growth stage in which GABA production efficiency was
not high. Therefore, the quantitative amount of GABA of
around 27 g/L was only produced in the cultivation ope-
rated for long time over 100 h [12,20,30].
In this study, for the enhanced production of GABA in
C. glutamicum, we employed E. coli GAD mutant that
has catalytic activity in expanded pH range up to pH 7.
In the flask cultivation at pH 7, the use of GAD mutant
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than that of wild-type GAD (Figure 1). With GAD mu-
tant, we also examined four different pH conditions
(pH 4, 5, 6 and 7) to find the optimal pH condition,
which might allow us to design for the conditions to
support higher cell growth as well as higher production
of GABA. By the cultivation of recombinant C. glutamicum
at culture pH of 4, very little amount of GABA was pro-
duced due to the poor cell growth even though GAD is re-
ported to be highly active at pH 4. As the culture pH
increased to 5, 6, and 7, cell growth rates and final cell
density were not much different but, a little higher GABA
concentration was obtained by cultivation at pH 5 (Figure 4
B). In flaks cultivation, we set only the initial pH in the
medium and the pHs were not adjusted during the cultiva-
tion. It is known that the production of GABA resulted in
the increase of pH due to the consuming protons in a de-
carboxylation reaction [31]. But, pH in the media can be
also affected by other factors including media compositions
and formation of organic acids byproducts (acetate, lactate,
citrate etc.) which cause the decrease of pH in the media
[32]. Actually, the initial pH in the medium decreased grad-
ually during the cultivation, and the decreased pH might
give an inhibitory effect on the cell growth. So, in flask cul-
tivations, there were not big difference in cell density and
so, under the similar cell density, more GABA might be
produced at lower pH condition because the engineered
GAD also has higher activity at lower pH than higher pH
although it has broad pH range for catalytic activity. How-
ever, in the fed-batch cultivation, pH could be adjusted to
set-point during the entire cultivation unlike as flask culti-
vations. Under each pH condition, cells exhibited much dif-
ferent cell growth profiles and, as expected, much higher
growth rate and cell density (up to OD600 of 160) could be
obtained at higher pHs (pH 6 and 7) than pH 5 (OD600
of 72). With this higher cell density, much higher
GABA production could be also obtained although the
GAD has lower activity at pH 6 than pH 5. It was also
clearly observed that the cell growth and GABA produc-
tion profiles were well associated at both pH conditions
(pH 5 and pH 6). During the exponential growth phase,
GABA production could initiate and GABA concentration
was gradually increased by the constitutive expression of
the engineered GAD gene under the strong synthetic pro-
moter (PH36) (Figure 5B). Thus, high GABA concentration
of 38.6 ± 0.85 g/L could be obtained by 72 h cultivation,
which was much shorter than 96~168 h cultivation times
in previous reports [11,12]. Also, the high productivity of
0.536 g/L/h could be obtained and, to the best of our
knowledge, this productivity is the highest record in
GABA production.
For the efficient production of target products, the
supply and consumption rates of precursors for the tar-
get products should be balanced enough to supporthigh-level production of target products without much
accumulation of unused precursors. In this study, the
optimal culture pH for the production of glutamate, the
direct precursor of GABA and the conversion of glutam-
ate into GABA might be different. The former is propor-
tional to culture pH up to 7 and the latter is inversely
proportional to culture pH. Also, the optimal condition
for cell growth is another factor to consider for en-
hanced production of GABA. It has been reported that
optimal pH of C. glutamicum growth is pH 7 to 8.5 and
inhibition of TCA occurred at low pH [33]. Since glu-
tamate is mainly converted from 2-oxoglutarate in TCA
cycle, optimal culture pH of glutamate production can
be found in the point that TCA cycle is inhibited without
much cell growth retardation to supply 2-oxoglutarate for
glutamate synthesis [34]. Besides efficient supply of glu-
tamate as precursor of GABA, optimal culture condition
for the conversion of glutamate into GABA by mutant
GAD should be designed for enhanced production of
GABA during cultivation of recombinant C. glutamicum.
As shown in the fermentation profiles obtained at the
culture pH 5, 6, and 7, the accumulation of glutamate
occurred in all the fed-bath cultivation, the extents of
which were different in each cultivation. In pH 5 and
6, glutamate accumulation was only observed in the
early stage of cultivation and glutamate was rapidly
consumed for the production of GABA resulting in no
further accumulation of glutamate in active GABA
synthesis phase. However, during the entire cultivation
of recombinant C. glutamicum at pH 7, large amount
of glutamate was accumulated in the culture medium
up to 18.9 ± 0.71 g/L, which resulted in rather low
GABA concentration of 9.86 ± 0.52 g/L. These fermen-
tation results clearly suggested several important fac-
tors affecting the production GABA through glutamate
from glucose should be considered to design the optimal
culture condition for enhanced production of GABA,
which include cell growth, synthesis of glutamate and
rapid conversion of synthesized glutamate into GABA
without much accumulation. In the cultivation at pH 6~7,
cells grew better than that at pH 5, and much more glu-
tamate could be produced (particularly in the stationary
growth phase). In the cultivation at pH 6, mutant GAD
was more active than at pH 7 and so, most glutamate pro-
duced in stationary phase could be converted to GABA
which might be also one reason for higher production of
GABA during the stationary growth phase although mu-
tant GAD was already produced and GABA began to be
produced in the exponential growth phase (Figure 5B). In
the cultivation of recombinant C. glutamicum at pH 7, ra-
ther low activity of mutant GAD that is not enough to
catch up with the glutamate synthesis seems to be main
reason for low production of GABA along with much ac-
cumulation of unused glutamate in the culture medium.
Table 1 Bacterial strains and plasmids used in this study
Strain Relevant characteristics Reference
or source
E. coli XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17
supE44 relA1 lac [F′ proABlacIq
ZΔM15 Tn10 (Tetr)]
Stratagenea
E. coli DH5α fhuA2 lac(del)U169 phoA
glnV44 Φ80' lacZ(del)M15
gyrA96 recA1 relA1 endA1
thi-1 hsdR17
Lab stock
C. glutamicum Wild type ATCC13032
Plasmids Relevant characteristics Reference or
source
pET28b-GAD ΔCE89Q gadB mutant (Glu89Gln/Δ452-466
gene)
[20]
pCES208 E. coli-C. Glutamicum shuttle
vector, Kmr
[40]
pCES-H36-GFP pCES208 derivative, PH36, eGFP [21]
pCES-I16-GFP pCES208 derivative, PI16, eGFP [21]
pCES-L26-GFP pCES208 derivative, PL26, eGFP [21]




pLGmut pCES208 derivative, PL26,
Glu89Gln/Δ452-466 gene
This study
pIGmut pCES208 derivative, PI16,
Glu89Gln/Δ452-466 gene
This study
aStratagene, La Jolla, CA, USA.
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ble condition for cell growth, much less glutamate might
be synthesized, which resulted in much lower production
of GABA compared with that of pH 6. In the culture
pH 6, increased GAD activity could be balanced for glu-
tamate synthesis to result in high-level production of
GABA up to 38.6 ± 0.85 g/L.
Conclusions
In this study, we have developed recombinant C. gluta-
micum strains for the enhanced production of GABA by
employing mutant GAD that has catalytic activity in
broadened pH range, which allowed us to obtain growth
associated production of GABA by modulating cell
growth, glutamate synthesis and conversion of glutamate
into GABA in balanced level. These were achieved by
strong synthetic promoter system supporting stable ex-
pression of the engineered gadB gene in high-level in re-
combinant C. glutamicum and optimization of culture
conditions to support both high cell growth and high
GABA production such as culture pH and biotin con-
centration. To our best knowledge, the productivity of
0.536 g/L/h for GABA synthesis is the highest among
those obtained in recombinant C. glutamcium from glucose.
Recently, several important nylon monomer precursors such
as 5-aminovalerate, cadaverine, and putrescine have been
produced by recombinant E. coli and C. glutamicum strains
employing different cultivation strategies using lysine and
glutamate as precursors [5,35-41]. Since C. glutamicum is
one of important industrial host strains for the production
of amino acids, metabolic engineering strategies developed
in this study can be further expanded for the development
of recombinant C. glutamicum to produce such nylon
monomer precursors from renewable resources.
Materials and methods
Bacterial strains, media and culture conditions
The bacterial strains and plasmids used in this study are
listed in Table 1. E. coli XL1-Blue was used as the host
for gene cloning and plasmid maintenance, and C. gluta-
micum ATCC 13032 was used as the host strain for the
expression of GAD and for the production of GABA. E.
coli was grown in Luria-Bertani (LB) medium containing
10 g/L tryptone, 5 g/L yeast extract and 5 g/L NaCl at
37°C. For cultivation of C. glutamicum in shake flasks,
Brain Heart Infusion (BHI, BD) and GP1 medium were
used. GP1 medium (pH 7.0) contained 50 g/L (NH4)2
SO4, 1 g/L K2HPO4, 3 g/L urea, 0.4 g/L MgSO4·7H2O,
50 g/L peptone, 0.01 g/L FeSO4, 0.01 g/L MnSO4·5H2O,
and 200 μg/L thiamine [14]. 0.1 mM Pyridoxal 5′-phos-
phate hydrate (PLP), biotin and glucose at different con-
centration were also added to GP1 medium to support
the growth of recombinant C. glutamicum. Thiamine,
biotin and PLP were prepared as stock solution using0.22 μm filter membrane and were added before cell cul-
tures. Glucose was also separately autoclaved and added
to the concentration of 50 g/L in shake flask cultures.
Kanamycin (Km, 25 μg/mL) was added to the culture
medium.
Construction of plasmids
Plasmids pCES-H36-GFP, pCES-I16-GFP, and pCES-L26-
GFP, which were constructed using E. coli-C. glutamicum
shuttle vector, pCES208 [42], have previously been de-
scribed [21]. They contain synthetic strong H36, inter-
mediate I16, and low L26 promoter, respectively, for the
expression of target gene in desired level in recombinant
C. glutamicum [21]. A polymerase chain reaction (PCR)
was performed using the C1000™ Thermal Cycler
(Bio-Rad, Hercules, CA, USA) with PrimeSTAR HS
polymerase (Takara Bio Inc., Shiga, Japan). The nu-
cleotide sequences of all the primers used in this
study are listed in Table 2. The wild type E. coli gadB
gene was amplified by PCR with primers Gad-del-C-F
and Gad-wt–R from chromosomal DNA of E. coli
DH5α. The E. coli mutant gadB gene for the expres-
sion of mutant GAD that contains one mutation of
E89Q and C-terminal deletion from 452 bp to 466 bp
was amplified by PCR with primers Gad-del-C-F and
Gad-del-C–R from pET28b-GAD ΔCE89Q [20]. Both
Table 2 List of primers used in PCR experimentsa








aRestriction enzyme sites are shown in bold.
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zymes (BamH1 and Not1) and then, cloned into the
same restriction enzyme sites of pCES-H36-GFP which
contains strong and constitutive promoter (PH36) to yield
pHGwt and pHGmut, respectively. For the gene expres-
sion under the intermediate strength promoter (PI16), PI16
promoter was amplified from pCES-I16-GFP by PCR with
primers I16-F and I16-R. The PCR product was digested
with KpnI and BamHI, and then cloned into pHGmut to
yield pIGmut. For the gene expression under the low
strength promoter (PL26), PL26 promoter was amplified
from pCES-L26-GFP by PCR with primers L26-F and
L26-R. After digestion with KpnI and BamHI, PCR prod-
uct was cloned into pHGmut to yield pLGmut. All plas-
mids were constructed in E. coli XL1-Blue and then
transformed into C. glutamicum ATCC 13032 by electro-
poration using a Gene Pulser (Bio-Rad). Manipulation of
DNA such as restriction enzyme digestion, ligation, and
agarose gel electrophoresis were carried out using stand-
ard procedures [43].
Cultivation in shake flasks
Recombinant C. glutamicum strain was first inoculated
in 10 mL brain heart infusion (BHI) medium containing
Km (25 μg/mL) and was cultivated at 30°C for 24 h with
200 rpm. Then, 2 mL of pre-culture was transferred into
50 mL of GP1 medium supplemented with PLP, biotin,
and Km in 250 mL shake flask for GABA production.
Cells were cultivated at 30°C for 96 h with 200 rpm.
Fed-batch cultivation
For seed culture, recombinant C. glutamicum harboring
pHGmut was inoculated into 200 mL of GP1 medium
containing 50 μg/L of biotin in 1 L baffled flask and was
cultivated at 30°C for 48 h with 200 rpm. The seed cul-
ture was transferred into 2 L of fresh GP1 medium con-
taining 100 g/L glucose in a 5-L jar bioreactor (BioCNS,
Daejeon, Republic of Korea). During the cultivation, the
temperature was maintained at 30°C. The pH and dis-
solved oxygen (DO) concentration were controlled at
the set points by on-line monitoring. The DO concen-
tration was maintained at 30% (v/v) by automaticallyincreasing the agitation speed up to 1,200 rpm and then
by mixing the pure oxygen through a gas mixer. Three
different pHs (5.0, 6.0 and 7.0) were examined and pHs
were controlled by adding 5 N ammonia solution. Glu-
cose as a sole carbon source was fed by a peristaltic
pump to maintain the concentration of glucose about
30 g/L during fed-batch culture. During the cultivation,
cell growth was monitored by measuring the optical
density at 600 nm (OD600) with a spectrophotometer
(Optizen POP; Mecays, Deajeon, Republic of Korea).Protein preparation and analysis
After flask cultivation, cells were harvested by centrifu-
gation at 6,000 rpm for 10 min at 4°C. The harvested
cells were re-suspended in phosphate-buffered saline
(PBS, 135 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4,
1.4 mM KH2PO4, pH 7.2) and were disrupted by sonic-
ation at 9 min at 50% pulse and 20% amplitude (Sonic,
Vibra cell, USA). After centrifugation of cell lysates at
10,000 rpm for 10 min at 4°C, soluble proteins were col-
lected from supernatant. In SDS-PAGE analysis, samples
were loaded on 12% polyacrylamide gels. After the gel
electrophoresis, the gels were stained with Coomassie
brilliant blue [50% (v/v) methanol, 10% (v/v) acetic acid,
1 g/L Coomassie brilliant blue R-250] for 1 hr and
destained using a destaining solution [10% (v/v) metha-
nol, 10% (v/v) acetic acid].Analysis of cell growth, GABA, L-glutamate and glucose
concentration
During the cultivation, the concentration of glucose in
the medium was determined by glucose analyzer (YSI
2700 SELECT™ Biochemistry Analyzer, YSI Life Science,
Yellow Springs, OH, USA). For analyzing the concen-
trations of GABA and L-glutamate, an appropriate vol-
ume of culture medium was centrifuged at 13,000 rpm
and 4°C for 10 min and, the supernatant was applied
to reversed phase high-pressure liquid chromatography
(HPLC, LC-20 AD, CTO-20A, SPD-20A; Shimadzu,
Japan) equipped with Zorbax Eclipse amino acid ana-
lysis (AAA) column (4.6 × 150 mm 3.5-Micron; Agilent,
USA). The separation of samples was attained using a bin-
ary non-linear gradient with mobile phase A (10 mM
Na2HPO4 – 10 mM Na2B4O7, pH 8.2) and mobile phase
B (acetonitrile:MeOH:H2O 45:45:10 by volume). Elution
condition was as follows: equilibration (1.9 min, 100% A),
gradient (16.2 min 0-57% B, 3.7 min 57-100% B), cleaning
(4 min, 100% B). The column temperature was maintained
at 40°C. Samples were detected at UV 338 nm. The stand-
ard curve for GABA and L-glutamate was determined
using same procedure for 4 standard solutions [0.125,
0.25, 0.5 and 1 g/L of GABA and L-glutamate (Sigma,
Missouri, USA)].
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